Please login to the form below

Not currently logged in
Email:
Password:

Eisai’s Bose to join Boehringer

He becomes head of global marketing for oncology

boehringer-uday-boseBoehringer Ingelheim has named Eisai's Uday Bose as head of global marketing for its oncology business.

Taking up the role on August 1, Bose will lead marketing efforts for Boehringer's fledgling activities in cancer, which has become an increasingly important area for the company since the launch of its first oncology product Giotrif (afatinib) last year.

Since then Boehringer has also filed its second cancer product nintedanib for approval in lung cancer.

Bose's responsibilities include the long-term marketing plan for the cancer portfolio, as well as the development of global strategies for Boehringer's cancer products and guiding the launch and marketing of individual drugs.

Bose is currently head of the oncology business unit for the EMEA region at Eisai – a position he has held since 2010. His past experience include senior marketing roles at GSK's oncology business and product manager positions at Sanofi.

14th July 2014

From: Sales, Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...